These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2656478)

  • 1. Liposomes as drug carriers in the therapy of infectious diseases.
    Juliano RL
    Horiz Biochem Biophys; 1989; 9():249-79. PubMed ID: 2656478
    [No Abstract]   [Full Text] [Related]  

  • 2. Liposomes in infectious diseases: present and future.
    Lopez-Berestein G
    Curr Clin Top Infect Dis; 1989; 10():241-53. PubMed ID: 2679695
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-circulating sterically stabilized liposomes in the treatment of infections.
    Bakker-Woudenberg IA; Schiffelers RM; Storm G; Becker MJ; Guo L
    Methods Enzymol; 2005; 391():228-60. PubMed ID: 15721385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The past, present, and future uses of liposomes in treating infectious diseases.
    Wasan KM; Lopez-Berestein G
    Immunopharmacol Immunotoxicol; 1995 Feb; 17(1):1-15. PubMed ID: 7759766
    [No Abstract]   [Full Text] [Related]  

  • 5. [Liposomes and infection. Therapeutic possibilities and current clinical findings].
    Coune A; Sculier JP; Meunier F; Brassinne C; Laduron C; Hollaert C
    Rev Med Liege; 1988 Sep; 43(18):577-81. PubMed ID: 3187259
    [No Abstract]   [Full Text] [Related]  

  • 6. The purview of nitric oxide nanoparticle therapy in infection and wound healing.
    Sanchez DA; Nosanchuk J; Friedman A
    Nanomedicine (Lond); 2012 Jul; 7(7):933-6. PubMed ID: 22642306
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-circulating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious foci.
    Bakker-Woudenberg IA
    Int J Antimicrob Agents; 2002 Apr; 19(4):299-311. PubMed ID: 11978501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of infectious diseases with liposome-encapsulated antibiotics].
    Hara K; Kohno S; Miyazaki T
    Nihon Rinsho; 1989 Jun; 47(6):1288-94. PubMed ID: 2769990
    [No Abstract]   [Full Text] [Related]  

  • 9. [From single dose to lipid forms].
    López JB; Gavilán MG
    Rev Esp Quimioter; 1998 Sep; 11(3):189-95. PubMed ID: 9795304
    [No Abstract]   [Full Text] [Related]  

  • 10. The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections.
    Tamilvanan S; Venkateshan N; Ludwig A
    J Control Release; 2008 May; 128(1):2-22. PubMed ID: 18342974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The animal rule and emerging infections: the role of clinical pharmacology in determining an effective dose.
    Bergman KL
    Clin Pharmacol Ther; 2009 Sep; 86(3):328-31. PubMed ID: 19571806
    [No Abstract]   [Full Text] [Related]  

  • 12. [Liposomes in the combined treatment of patients with chronic obstructive bronchitis].
    Novikova RI; Chernyĭ VI; Stefanov AV; Akhlamova IuI
    Ter Arkh; 1993; 65(3):40-3. PubMed ID: 8059382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits.
    Cabanes A; Reig F; Antón JM; Arboix M
    Am J Vet Res; 1995 Nov; 56(11):1498-501. PubMed ID: 8585663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antimicrobial activity of liposomal meropenem against Pseudomonas aeruginosa strains.
    Drulis-Kawa Z; Gubernator J; Dorotkiewicz-Jach A; Doroszkiewicz W; Kozubek A
    Int J Pharm; 2006 Jun; 315(1-2):59-66. PubMed ID: 16551496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic antidepressive strategies in a depressed patient presenting with a chronic infectious pathology].
    Poirier MF
    Encephale; 1997 Dec; 23 Spec No 5():43-8. PubMed ID: 9488920
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of liposomal enrofloxacin for intracellular infections in Kangal dogs and visualization of phagocytosis of liposomes.
    Deĝim Z; Deĝim T; Bas L; Elmas M
    J Biomed Mater Res; 2002 Aug; 61(2):246-51. PubMed ID: 12007205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of central nervous system infections in small animals.
    Fenner WR
    J Am Vet Med Assoc; 1984 Nov; 185(10):1176-80. PubMed ID: 6392251
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibiotic therapy in serious infectious states].
    Carlet J; Tabah A
    Med Mal Infect; 2006 Jun; 36(6):299-303. PubMed ID: 16698210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious disease, 1982. State of the Art.
    Weinstein L
    Clin Ther; 1982; 4(5):340-3. PubMed ID: 7066933
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications.
    Pinto-Alphandary H; Andremont A; Couvreur P
    Int J Antimicrob Agents; 2000 Jan; 13(3):155-68. PubMed ID: 10724019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.